Literature DB >> 19838931

Nutritional factors in ovarian cancer survival.

Elisa V Bandera1, Lawrence H Kushi, Lorna Rodriguez-Rodriguez.   

Abstract

Ovarian cancer is the leading cause of death from gynecologic malignancies in the United States. Because symptoms tend be nonspecific, early detection is difficult, and most ovarian cancers are diagnosed at an advanced stage when the prognosis is poor. Nonetheless, there is clinical evidence that even given the same tumor characteristics (histologic type, stage, and grade), some cases experience much better survival than others. This has led to extensive research on molecular prognostic factors to enable more efficient and targeted therapeutic regimens. However, little is known about the impact that lifestyle factors, such as diet or physical activity, may have in the prognosis of ovarian cancer, whether on disease-free survival or on the response to and complications from treatment. The role of obesity on ovarian cancer survival is unclear. Obesity may delay diagnosis, hinder optimal surgical and cytotoxic treatment, and cause postoperative complications. As overweight and obesity rates reach epidemic proportions, the impact of body mass index in the clinical management of ovarian cancer is increasingly significant, whereas current evidence of its impact is limited and inconclusive.

Entities:  

Mesh:

Year:  2009        PMID: 19838931     DOI: 10.1080/01635580902825670

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  11 in total

1.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.

Authors:  Marcin Mardas; Marta Stelmach-Mardas; Radosław Madry
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

2.  Clinical research device for ovarian cancer detection by optical spectroscopy in the ultraviolet C-visible.

Authors:  Ronie George; Archana Chandrasekaran; Molly A Brewer; Kenneth D Hatch; Urs Utzinger
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

3.  Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  Hepatol Int       Date:  2012-10-26       Impact factor: 6.047

Review 4.  Impact of Diet, Body Mass Index, and Physical Activity on Cancer Survival.

Authors:  Ellen Kampman; Alina Vrieling; Fränzel J van Duijnhoven; Renate M Winkels
Journal:  Curr Nutr Rep       Date:  2012-01-07

5.  The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian Cancer.

Authors:  Wan Kyu Eo; Hye Jung Chang; Sang Hoon Kwon; Suk Bong Koh; Young Ok Kim; Yong Il Ji; Hong-Bae Kim; Ji Young Lee; Dong Soo Suh; Ki Hyung Kim; Ik Jin Chang; Heung Yeol Kim; Suk Choo Chang
Journal:  J Cancer       Date:  2016-01-29       Impact factor: 4.207

6.  Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer.

Authors:  Jiangdong Xiang; Lina Zhou; Xing Li; Wei Bao; Taizhong Chen; Xiaowei Xi; Yinyan He; Xiaoping Wan
Journal:  Transl Oncol       Date:  2016-11-24       Impact factor: 4.243

7.  Pre-diagnosis diet and survival after a diagnosis of ovarian cancer.

Authors:  Mary C Playdon; Christina M Nagle; Torukiri I Ibiebele; Leah M Ferrucci; Melinda M Protani; Jonathan Carter; Simon E Hyde; Deborah Neesham; James L Nicklin; Susan T Mayne; Penelope M Webb
Journal:  Br J Cancer       Date:  2017-05-02       Impact factor: 7.640

8.  Exploring the malnutrition status and impact of total parenteral nutrition on the outcome of patients with advanced stage ovarian cancer.

Authors:  Xin Yan; Sanyuan Zhang; Junmei Jia; Jiaolin Yang; Yilai Song; Haoran Duan
Journal:  BMC Cancer       Date:  2021-07-10       Impact factor: 4.430

9.  Dietary fat intake and risk of epithelial ovarian cancer by tumour histology.

Authors:  M A Merritt; D W Cramer; S A Missmer; A F Vitonis; L J Titus; K L Terry
Journal:  Br J Cancer       Date:  2014-01-28       Impact factor: 7.640

10.  Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer.

Authors:  Wankyu Eo; Hong-Bae Kim; Yong Joo Lee; Dong Soo Suh; Ki Hyung Kim; Heungyeol Kim
Journal:  J Cancer       Date:  2016-08-11       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.